Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05627856Phase 1/2Active Not Recruiting
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
NK/T Cell LymphomaNon-Hodgkin LymphomaVascular Immunomother T Cell Lymphoma
PrincipalinvestigatorStart date: 2023-02-21
Relmacabtagene Autoleucel in Patients With LBCL
Large B-cell Lymphoma
PrincipalinvestigatorStart date: 2022-12-28

Research Network

Collaboration Network

25 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Wenyu Li, PHD

Guangdong Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

NK/T Cell LymphomaLymphoma, Non-HodgkinVascular Immunomother T Cell Lymphoma

Worked with same sponsors:

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Sichuan Baili Pharmaceutical Co., Ltd.+1 more
Collaborated on 1 trial
Similarity Score34%

Huilai Zhang

Tianjin Cancer Hospital Airport Hospital

Related
3 trials

Shared therapeutic areas:

Large B-cell LymphomaLymphoma, Non-Hodgkin

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Weili Zhao, PhD

Ruijin Hospital

Related
5 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Dehui Zou

Hematology Hospital, Chinese Academy of Medical Sciences

Related
1 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Zhifeng Li

The First Hospital of Xiamen University

Related
1 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Qingyuan Zhang

Harbin Medical University Tumor Hospital

Related
1 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

heng Mei

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Jianqiu Wu

Jiangsu Provincial Tumor Hospital

Related
1 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Liang Huang, PhD

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China

Related
1 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Large B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05627856Phase 1/2PrincipalInvestigator

A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

NK/T Cell LymphomaNon-Hodgkin LymphomaVascular Immunomother T Cell Lymphoma
Active Not Recruiting
NCT06142175PrincipalInvestigator

Relmacabtagene Autoleucel in Patients With LBCL

Large B-cell Lymphoma
Unknown

All 2 trials loaded